Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SEER | US
-0.03
-1.75%
Healthcare
Biotechnology
30/06/2024
30/08/2024
1.68
1.68
1.70
1.68
Seer Inc. a life sciences company engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite an integrated solution that comprises consumables an automation instrumentation and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research and clinical trials. The company intends to sell its products for research purposes which cover academic institutions life sciences and research laboratories as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer Inc. has a collaboration agreement with Oregon Health & Science University; The Broad Institute of MIT and Harvard; Discovery Life Sciences LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences Inc. and changed its name to Seer Inc. in July 2018. Seer Inc. was incorporated in 2017 and is headquartered in Redwood City California.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
37.6%1 month
37.3%3 months
52.8%6 months
56.9%-
-
0.28
0.07
0.07
1.72
0.11
-
-94.34M
103.20M
103.20M
-
-882.03
-
-23.40
-21.06
2.12
1.39
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.15
Range1M
0.47
Range3M
0.58
Rel. volume
0.50
Price X volume
257.24K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ELEDON PHARMACEUTICALS INC | ELDN | Biotechnology | 2.81 | 111.43M | -1.40% | 6.24 | -7.70% |
Agenus Inc | AGEN | Biotechnology | 5.15 | 111.10M | 3.21% | n/a | -170.56% |
Leap Therapeutics Inc | LPTX | Biotechnology | 2.9 | 110.97M | 2.47% | n/a | 0.73% |
Regulus Therapeutics Inc | RGLS | Biotechnology | 1.68 | 109.98M | 1.82% | n/a | 1.45% |
bluebird bio Inc | BLUE | Biotechnology | 0.5615 | 108.22M | -5.22% | n/a | 136.48% |
CRDF | CRDF | Biotechnology | 2.31 | 107.53M | 0.43% | n/a | 3.52% |
Checkpoint Therapeutics Inc | CKPT | Biotechnology | 2.35 | 105.79M | 0.43% | n/a | 0.00% |
Adlai Nortye Ltd. | ANL | Biotechnology | 2.8334 | 104.55M | 3.03% | n/a | 38.82% |
Dermira Inc | DERM | Biotechnology | 4.98 | 103.22M | -4.41% | 38.31 | 201.92% |
Assembly Biosciences Inc | ASMB | Biotechnology | 16.26 | 103.18M | 1.06% | n/a | 5.03% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Saga Communications Inc | SGA | Broadcasting - Radio | 14.72 | 92.17M | -2.06% | 14.72 | 7.10% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.38 | 76.89M | 5.34% | n/a | 268.43% |
Emmis Communications Corporation | EMMS | Broadcasting - Radio | 4.7 | 57.98M | -1.05% | n/a | 54.59% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 3.68 | 39.85M | -1.12% | n/a | 54.96% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.34 | 28.51M | 13.04% | n/a | 16.03% |
ILAG | ILAG | Building Products & Equipment | 1.25 | 22.57M | 6.84% | n/a | 5.48% |
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 0.6131 | 18.67M | -4.20% | n/a | 204.46% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2495 | 3.93M | 5.94% | n/a | 0.00% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.391 | 3.72M | -6.28% | n/a | 19.98% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.45 | 3.70M | 13.28% | n/a | 9.62% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 1.72 | 0.97 | Expensive |
Ent. to Revenue | 0.11 | 3,681.29 | Cheaper |
PE Ratio | - | 39.83 | - |
Price to Book | 0.28 | 14.54 | Cheaper |
Dividend Yield | - | 2.19 | - |
Std. Deviation (3M) | 52.82 | 76.13 | Lower Risk |
Debt to Equity | 0.07 | -2.05 | Expensive |
Debt to Assets | 0.07 | 0.25 | Cheaper |
Market Cap | 103.20M | 4.04B | Emerging |